These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 428120)

  • 1. [Clinical effects of "Secrepan", a secretin preparation, on duodenal ulcer].
    Ishikawa M; Kataoka S; Ueno T; Takahashi T; Goto T
    Horumon To Rinsho; 1979 Jan; 27(1):115-20. PubMed ID: 428120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secretin as a possible therapeutic agent in ulcer disease].
    Geller LI; Glinskaia TP; Kozlova ZP
    Vrach Delo; 1974 Dec; (12):55-8. PubMed ID: 4446534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of duodenal ulcer with synthetic depot secretin - a double-blind study].
    Scholten T; Fritsch WP; Hagenmüller F; Classen M; Knop P; Hausamen TU; Lingenberg G; Portocarrero G; Safrany L; Seifert E; Zeus U; Stadelmann O
    Z Gastroenterol; 1983 May; 21(5):212-9. PubMed ID: 6349151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of exogenous secretin in the treatment of duodenal ulcer pain.
    Höj L; Holst JJ; Rune SJ
    Scand J Gastroenterol; 1973; 8(3):279-81. PubMed ID: 4724928
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of duodenal ulcer with a long-acting synthetic secretin: a pilot trial.
    Demling L; Domschke W; Domschke S; Belohlavek D; Baenkler HW; Frühmorgen P; Lingenberg G; Wünsch E; Jaeger E
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):310-3. PubMed ID: 53980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal effects of long-term treatment of duodenal ulcer with depot secretin: clinical, secretory, ultra-structural, and enzymological aspects.
    Demling L; Domschke W; Riemann JF; Domschke S; Ruppin H; Junge O; Wünsch E
    Scand J Gastroenterol Suppl; 1976; 42():136-45. PubMed ID: 796967
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with synthetic secretin in the treatment of duodenal ulcer.
    Henn RM; Selcon S; Sturdevant RA; Isenberg JI; Grossman MI
    Am J Dig Dis; 1976 Nov; 21(11):921-5. PubMed ID: 790943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hemorrhage from acute gastric and duodenal mucosa lesions with secretin].
    Becker HD; Schafmayer A; Börger HW
    Chirurg; 1979 Feb; 50(2):87-90. PubMed ID: 369794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of duodenal ulcer with secretin: a speculative proposal.
    Grossman MI
    Gastroenterology; 1966 Jun; 50(6):912-3. PubMed ID: 5212382
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of GIH and Boots secretin and cholecystokinin on duodenal ulcers in the rat.
    Joffe SN; Ferrie MM
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):458-61. PubMed ID: 602624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of pancreatic secretion in man by secretin snuff.
    B'Hend P; Hadorn B; Haldemann B; Kleeb M; Lüthi H
    Lancet; 1973 Mar; 1(7802):509-10. PubMed ID: 4119948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes of the exocrine pancreatic function and results of secretin therapy in duodenal ulcer].
    Brailski VC; Mendisova A; Dimitrov B
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):245-7. PubMed ID: 1021403
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical studies on therapeutic effect of secretin in ulcer].
    Matsuo H; Seki A; Ishikawa T
    Horumon To Rinsho; 1975 May; 23(5):507-12. PubMed ID: 1170050
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of subcutaneous and intravenous secretin in man.
    Isenberg JI; Grossman MI
    Gastroenterology; 1969 Jan; 56(1):88-91. PubMed ID: 5765434
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic use of secretin].
    Kornilova SN
    Vrach Delo; 1976 Aug; (8):47-51. PubMed ID: 1020290
    [No Abstract]   [Full Text] [Related]  

  • 16. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment.
    Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA
    Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of continuous intravenous infusion of secretin preparation (secrepan) in patients with hemorrhage from chronic peptic ulcer and acute gastric mucosal lesion (AGML).
    Watanabe Y; Tsumura H; Sasaki H
    Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():86-9. PubMed ID: 1884969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Anaphylactoid skin reaction after intradermal secretin.
    Baenkler HW; Domschke W; Domschke S; Demling L; Wunsch E; Jaeger E
    Br Med J; 1975 Jun; 2(5973):747-8. PubMed ID: 1139208
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gastroduodenal motility in duodenal ulcer before and after administration of secretin].
    Skuia NA; Danilans AIa
    Ter Arkh; 1977; 49(9):83-7. PubMed ID: 929425
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secretin: diagnostic and therapeutic significance].
    Schneider MU
    Fortschr Med; 1984 Apr; 102(16):475-6. PubMed ID: 6724481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.